COVID-19 will remain the third-largest killer for 2022, behind heart disease and cancer, even with the reduced numbers
Deaths Mentioning Long COVID Identified in United States
Percentage of COVID-19 deaths with long COVID peaked in June 2021 and April 2022 at 1.2 and 3.8 percent
Postop CV Morbidity Down With Increased Time From COVID-19 to Surgery
Odds of major postoperative cardiovascular morbidity reduced with increased time from COVID-19 diagnosis to surgery
Moderna, Merck Report on Promising Melanoma Vaccine
Companies announced that the vaccine performed well in a small study of patients who had the cancer surgically removed
Severity of Acute COVID-19 Tied to Frequency of Long COVID Diagnosis
Female sex and previous mental health disorders, asthma associated with long COVID, regardless of COVID-19 severity
Post-COVID-19 Syndrome Triples Use of Further Health Care Services
Female sex and high BMI associated with an increased risk for post-COVID-19 syndrome
Children Report Changing Symptoms in Year Following COVID-19
However, most symptoms decline in prevalence by 12 months
Females, Some Minorities Underrepresented in COVID-19 Clinical Trials
Females underrepresented in treatment trials, while Asian, Black participants underrepresented in prevention trials
Nirmatrelvir Plus Ritonavir Reduces Risks for COVID-19 in Seniors
Reduced risks for hospitalization and death observed for mainly vaccinated outpatients aged 50 years or older with COVID-19
Preprint, Peer-Reviewed Pairs of Studies Generally Concordant
Sample sizes, primary end points, interpretations mainly concordant for studies published on medRxiv, then in journals